Novo Nordisk A/S header image

Novo Nordisk A/S

NOVO B

Equity

ISIN DK0062498333 / Valor 129508879

Nasdaq Copenhagen Equities (2026-10-30)
DKK 266.10+2.21%

Novo Nordisk A/S
UMushroom community rating:

star star star star star
4.00 19 votes No rating yet
NegativeNeutralPositive

About company

Novo Nordisk A/S, founded in 1923 and headquartered near Copenhagen, Denmark, is a leading global healthcare company specializing in the development, manufacturing, and marketing of pharmaceutical products. The company is renowned for its extensive range of diabetes care solutions, including various insulin therapies and innovative treatments aimed at improving patient outcomes. In addition to diabetes, Novo Nordisk also focuses on other therapeutic areas such as obesity, hemophilia, and growth disorders, leveraging advanced biotechnology to address unmet medical needs. Committed to research and development, Novo Nordisk invests significantly in scientific advancements to maintain its position in the competitive biopharmaceutical industry. The company's long-standing dedication to improving health through sustainable and effective treatments underscores its role as a key player in the global healthcare market.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

-17.5%1Y
-60.7%3Y
-24.4%5Y

Performance

47.6%1Y
45.4%3Y
40.4%5Y

Volatility

Market cap

133813 M

Market cap (USD)

Daily traded volume (Shares)

6,661,279

Daily traded volume (Shares)

1 day high/low

645.6 / 626.4

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

4.00

19 votes
Performance:
starstarstarstarstar
3.46
Innovation:
starstarstarstarstar
4.03
Society:
starstarstarstarstar
4.03
Nature:
starstarstarstarstar
3.69
Corbin Newbury
UK, 09 Nov 2025
star star star star star
.
Faraz Abedi
UK, 07 Nov 2025
star star star star star
Good upside
Jules Broglin
Switzerland, 30 Oct 2025
star star star star star
A socially impactful and financially strong healthcare innovator, combining medical leadership and sustainability with consistent long-term growth potential.

EQUITIES OF THE SAME SECTOR

Galapagos NV
Galapagos NV Galapagos NV Valor: 2130343
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.07%EUR 28.92
Terveystalo Oyj
Terveystalo Oyj Terveystalo Oyj Valor: 37893402
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.50%EUR 6.04
Siemens Healthineers AG
Siemens Healthineers AG Siemens Healthineers AG Valor: 40652181
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.00%EUR 42.89
Beiersdorf AG
Beiersdorf AG Beiersdorf AG Valor: 324660
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.48%EUR 82.80
Fresenius SE & Co. KGaA
Fresenius SE & Co. KGaA Fresenius SE & Co. KGaA Valor: 332902
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.69%EUR 47.80
Carl Zeiss Meditec AG
Carl Zeiss Meditec AG Carl Zeiss Meditec AG Valor: 1055489
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.63%EUR 34.98
Fresenius Medical Care AG
Fresenius Medical Care AG Fresenius Medical Care AG Valor: 520878
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-2.58%EUR 40.40
Denali Therapeutics Inc
Denali Therapeutics Inc Denali Therapeutics Inc Valor: 39149539
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.97%USD 18.94
Dermapharm Holding SE
Dermapharm Holding SE Dermapharm Holding SE Valor: 40166352
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.00%EUR 38.55
Formycon AG
Formycon AG Formycon AG Valor: 12194189
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.15%EUR 18.88